Aevum is pioneering the discovery and development of therapeutic molecules derived from exercise to treat disease. Our lead program is a first-in-class therapy for the treatment of Parkinson’s and other related neurodegenerative disorders.
Aevum is pioneering the discovery and development of therapeutic molecules derived from exercise to treat disease. Our lead program is a first-in-class therapy for the treatment of Parkinson’s and other related neurodegenerative disorders.